New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
16:29 EDTUSNAUsana sees FY13 EPS $5.10-$5.25, consensus $4.84
Sees FY13 revenue $700M-$720M, consensus $689.5M.
News For USNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 7, 2015
12:31 EDTUSNANu Skin plummets after cutting Q3 revenue outlook
Shares of Nu Skin (NUS), a global direct selling company, are sinking after the company lowered its third quarter revenue outlook. WHAT'S NEW: Tuesday after the bell, Nu Skin lowered its Q3 revenue view to $570M-$573M from $600M-$620M, well below analysts' consensus estimates of $621.55M. Foreign currency headwinds associated with the strengthening of the U.S. dollar negatively impacted revenue by more than $60M compared to the prior-year period. The revised revenue range is expected to represent continued improvement on a sequential basis, and the company continues to forecast constant-currency revenue growth in the fourth quarter of 2015 versus the prior year. WHAT'S NOTABLE: Truman Hunt, Nu Skin's Chief Executive Officer, noted, "Third quarter results were impacted by lower-than-expected sales of our new cosmetic oils in China during August and September, which may be a reflection of economic conditions in China." Hunt continued, "Our third quarter results will be in-line with expectations, with the exception of the Greater China region. Revenue growth in the third quarter was particularly strong in South Asia/Pacific, where our first introduction of ageLOC Youth drove more than 20% growth in that region, or more than 40% on a constant-currency basis. Given the successful launch of ageLOC Youth in South Asia/Pacific, we look forward to the introduction of ageLOC Youth as well as ageLOC Me in most of our regions during the fourth quarter. We forecast year-over-year constant-currency revenue growth of between 7%-10% in the fourth quarter." ANALYST REACTION: Sentiment on the Street was cautious at midday. Research firm Stifel downgraded Nu Skin to Sell from Hold, citing the company's negative pre-announcement and its deteriorating trends in Greater China. Its price target for shares is $35. Another firm, Canaccord, noted that NuSkin pre-announced revenue numbers that were below guidance, which suggests softer trends in China and the long awaited sustainable turn in momentum has failed to materialize. The firm expects a new product cycle to help support the return to growth. Canaccord maintained its Hold rating and lowered its price target to $45 from $48 on NuSkin shares. PRICE ACTION: In midday trading, Nu Skin fell $12.13, or about 26%, to $34.45 on about six times its average daily trading volume. OTHERS TO WATCH: Other companies in the direct selling business include Herbalife (HLF), down 9.2%, Estee Lauder (EL), down fractionally, USANA Health Sciences (USNA) down 8.4%, Avon Products (AVP) up almost 8%, and Tupperware Brands (TUP), up 2.5%.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use